|
| |
| | 67758 | | 01.02.2021 | | Novartis Pharma Schweiz AG | | | | | | 31.01.2026 | | | | | | 01.99. | | | | 01.99. | | IP |
| Seq.-No. | Product | Description | Galenic form | ATC-classification | |
---|
01 | Kesimpta | Injektionslösung in Fertigpen | Injektionslösung in Fertigpen (Ofatumumabum 20mg / 0.4ml) | L04AA52 | CI | 02 | Kesimpta | | (Ofatumumabum 20 mg) | | |
|
|
|